Research ArticleArticle
Reliability and Clinically Important Improvement Thresholds for Osteoarthritis Pain and Function Scales: A Multicenter Study
Jasvinder A. Singh, Ruili Luo, Glenn C. Landon and Maria Suarez-Almazor
The Journal of Rheumatology January 2014, jrheum.130609; DOI: https://doi.org/10.3899/jrheum.130609
Jasvinder A. Singh
From the Medicine Service, Birmingham VA Medical Center and Department of Medicine, University of Alabama; Center for Surgical Medical Acute Care Research and Transitions, Birmingham VA Medical Center; Division of Epidemiology, School of Public Health, University of Alabama, Birmingham, Alabama; Departments of Health Sciences Research and Orthopedic Surgery, Mayo Clinic School of Medicine, Rochester, Minnesota; Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center; St. Luke’s Episcopal Health System, Houston, Texas, USA. Supported by US National Institutes of Health Clinical Translational Science Award 1 KL2 RR024151-01 (Mayo Clinic Center for Clinical and Translational Research), and the resources and facilities at the Birmingham VA Medical Center, Alabama, USA. The original study was supported by unrestricted grants to scientific societies (Osteoarthritis Research Society International and Outcome Measures in Rheumatology) from pharmaceutical companies: Pfizer, Expansciences, Novartis, Negma Lerads, Rottapharm, Fidia, and Pierre Fabre Santé laboratories, and a research grant from the European League Against Rheumatism. Dr. Suarez-Almazor is the recipient of a K24 award from the National Institute for Arthritis, Musculoskeletal, and Skin Disorders (AR053593). Dr. Singh has received research and travel grants from Takeda and Savient, and consultant fees from Savient, Regeneron, Takeda, and Allergan. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. J.A. Singh, MBBS, MPH, Medicine Service, Center for Surgical Medical Acute Care Research and Transitions, Birmingham VA Medical Center, and Department of Medicine, University of Alabama, and Division of Epidemiology, School of Public Health, University of Alabama, and Departments of Health Sciences Research and Orthopedic Surgery, Mayo Clinic School of Medicine; R. Luo, PhD, Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center; G.C. Landon, MD, St. Luke’s Episcopal Health System; M. Suarez- Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center. Address correspondence to Dr. Singh, University of Alabama, Faculty Office Tower 805B, 510 20th Street S, Birmingham, Alabama 35294, USA. E-mail: Jasvinder.md@gmail.com Accepted for publication October 8, 2013.
Ruili Luo
From the Medicine Service, Birmingham VA Medical Center and Department of Medicine, University of Alabama; Center for Surgical Medical Acute Care Research and Transitions, Birmingham VA Medical Center; Division of Epidemiology, School of Public Health, University of Alabama, Birmingham, Alabama; Departments of Health Sciences Research and Orthopedic Surgery, Mayo Clinic School of Medicine, Rochester, Minnesota; Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center; St. Luke’s Episcopal Health System, Houston, Texas, USA. Supported by US National Institutes of Health Clinical Translational Science Award 1 KL2 RR024151-01 (Mayo Clinic Center for Clinical and Translational Research), and the resources and facilities at the Birmingham VA Medical Center, Alabama, USA. The original study was supported by unrestricted grants to scientific societies (Osteoarthritis Research Society International and Outcome Measures in Rheumatology) from pharmaceutical companies: Pfizer, Expansciences, Novartis, Negma Lerads, Rottapharm, Fidia, and Pierre Fabre Santé laboratories, and a research grant from the European League Against Rheumatism. Dr. Suarez-Almazor is the recipient of a K24 award from the National Institute for Arthritis, Musculoskeletal, and Skin Disorders (AR053593). Dr. Singh has received research and travel grants from Takeda and Savient, and consultant fees from Savient, Regeneron, Takeda, and Allergan. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. J.A. Singh, MBBS, MPH, Medicine Service, Center for Surgical Medical Acute Care Research and Transitions, Birmingham VA Medical Center, and Department of Medicine, University of Alabama, and Division of Epidemiology, School of Public Health, University of Alabama, and Departments of Health Sciences Research and Orthopedic Surgery, Mayo Clinic School of Medicine; R. Luo, PhD, Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center; G.C. Landon, MD, St. Luke’s Episcopal Health System; M. Suarez- Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center. Address correspondence to Dr. Singh, University of Alabama, Faculty Office Tower 805B, 510 20th Street S, Birmingham, Alabama 35294, USA. E-mail: Jasvinder.md@gmail.com Accepted for publication October 8, 2013.
Glenn C. Landon
From the Medicine Service, Birmingham VA Medical Center and Department of Medicine, University of Alabama; Center for Surgical Medical Acute Care Research and Transitions, Birmingham VA Medical Center; Division of Epidemiology, School of Public Health, University of Alabama, Birmingham, Alabama; Departments of Health Sciences Research and Orthopedic Surgery, Mayo Clinic School of Medicine, Rochester, Minnesota; Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center; St. Luke’s Episcopal Health System, Houston, Texas, USA. Supported by US National Institutes of Health Clinical Translational Science Award 1 KL2 RR024151-01 (Mayo Clinic Center for Clinical and Translational Research), and the resources and facilities at the Birmingham VA Medical Center, Alabama, USA. The original study was supported by unrestricted grants to scientific societies (Osteoarthritis Research Society International and Outcome Measures in Rheumatology) from pharmaceutical companies: Pfizer, Expansciences, Novartis, Negma Lerads, Rottapharm, Fidia, and Pierre Fabre Santé laboratories, and a research grant from the European League Against Rheumatism. Dr. Suarez-Almazor is the recipient of a K24 award from the National Institute for Arthritis, Musculoskeletal, and Skin Disorders (AR053593). Dr. Singh has received research and travel grants from Takeda and Savient, and consultant fees from Savient, Regeneron, Takeda, and Allergan. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. J.A. Singh, MBBS, MPH, Medicine Service, Center for Surgical Medical Acute Care Research and Transitions, Birmingham VA Medical Center, and Department of Medicine, University of Alabama, and Division of Epidemiology, School of Public Health, University of Alabama, and Departments of Health Sciences Research and Orthopedic Surgery, Mayo Clinic School of Medicine; R. Luo, PhD, Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center; G.C. Landon, MD, St. Luke’s Episcopal Health System; M. Suarez- Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center. Address correspondence to Dr. Singh, University of Alabama, Faculty Office Tower 805B, 510 20th Street S, Birmingham, Alabama 35294, USA. E-mail: Jasvinder.md@gmail.com Accepted for publication October 8, 2013.
Maria Suarez-Almazor
From the Medicine Service, Birmingham VA Medical Center and Department of Medicine, University of Alabama; Center for Surgical Medical Acute Care Research and Transitions, Birmingham VA Medical Center; Division of Epidemiology, School of Public Health, University of Alabama, Birmingham, Alabama; Departments of Health Sciences Research and Orthopedic Surgery, Mayo Clinic School of Medicine, Rochester, Minnesota; Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center; St. Luke’s Episcopal Health System, Houston, Texas, USA. Supported by US National Institutes of Health Clinical Translational Science Award 1 KL2 RR024151-01 (Mayo Clinic Center for Clinical and Translational Research), and the resources and facilities at the Birmingham VA Medical Center, Alabama, USA. The original study was supported by unrestricted grants to scientific societies (Osteoarthritis Research Society International and Outcome Measures in Rheumatology) from pharmaceutical companies: Pfizer, Expansciences, Novartis, Negma Lerads, Rottapharm, Fidia, and Pierre Fabre Santé laboratories, and a research grant from the European League Against Rheumatism. Dr. Suarez-Almazor is the recipient of a K24 award from the National Institute for Arthritis, Musculoskeletal, and Skin Disorders (AR053593). Dr. Singh has received research and travel grants from Takeda and Savient, and consultant fees from Savient, Regeneron, Takeda, and Allergan. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. J.A. Singh, MBBS, MPH, Medicine Service, Center for Surgical Medical Acute Care Research and Transitions, Birmingham VA Medical Center, and Department of Medicine, University of Alabama, and Division of Epidemiology, School of Public Health, University of Alabama, and Departments of Health Sciences Research and Orthopedic Surgery, Mayo Clinic School of Medicine; R. Luo, PhD, Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center; G.C. Landon, MD, St. Luke’s Episcopal Health System; M. Suarez- Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas, M.D. Anderson Cancer Center. Address correspondence to Dr. Singh, University of Alabama, Faculty Office Tower 805B, 510 20th Street S, Birmingham, Alabama 35294, USA. E-mail: Jasvinder.md@gmail.com Accepted for publication October 8, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Reliability and Clinically Important Improvement Thresholds for Osteoarthritis Pain and Function Scales: A Multicenter Study
Jasvinder A. Singh, Ruili Luo, Glenn C. Landon, Maria Suarez-Almazor
The Journal of Rheumatology Jan 2014, jrheum.130609; DOI: 10.3899/jrheum.130609